LYT-100 will be evaluated in patients with persistent symptoms caused by COVID-19

Updated Date: Fri, 27 Nov 2020 00:00:00 EST

Updated Date: Fri, 27 Nov 2020 00:00:00 EST

Updated Date: Fri, 27 Nov 2020 00:00:00 EST

Updated Date: Fri, 27 Nov 2020 00:00:00 EST

Treatment of SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses virus transmission within 24 […]

Scientists used human white blood cell membranes to carry two drugs, an antibiotic and an anti-inflammatory, directly to […]

Researchers from Skoltech and the University of Texas at Austin have presented a proof-of-concept for a wearable sensor […]

During the COVID-19 pandemic, health care professionals and researchers have been confined mostly to using local and national […]

NHS England has proposed abolishing clinical commissioning groups (CCGs) by April 2022 and moving their functions to statutory […]